Publication Cover
Redox Report
Communications in Free Radical Research
Volume 5, 2000 - Issue 2-3
285
Views
42
CrossRef citations to date
0
Altmetric
Miscellany

Tissue distribution of indoleamine 2,3-dioxygenase in normal and malaria-infected tissue

, , , &
Pages 112-115 | Published online: 19 Jul 2013

REFERENCES

  • Mellor AL, Munn DH. Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation? Immunol Today 1999; 20: 469–473.
  • Heyes MP, Brew BJ, Martin A et al. Kynurenic acid blocks neurotoxicity and seizures induced in rats by the brain metabolite quinolinic acid. Neurosci Lett 1984; 48: 273–278.
  • Heyes MR Saito K, Crowley JS et al. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain 1992; 115: 1249–1273.
  • Leib SL, Kim YS, Ferriero DM, Tuber MG. Neuroprotective effect of excitatory amino acid antagonist kynurenic acid in experimental bacterial meningitis. J Infect Dis 1996; 173: 166–171.
  • Sanni LA, Thomas SR, Tattam BN et al. Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and non-cerebral malaria. Am J Pathol 1998; 152: 611–619.
  • Bianchi M, Bertini R, Ghezzi P. Induction of indoleamine dioxygenase by interferon in mice: a study of different recom-binant interferons and various cytokines. Biochem Biophys Res Commun 1988; 152: 237–242.
  • Neill AL, Hunt NH. Pathology of fatal and resolving Plasmo-dium berghei cerebral malaria in mice. Parasitology 1992; 105: 165–175.
  • Pfefferkorn ER. Interferon-gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc Natl Acad Sci USA 1984; 81: 908–912.
  • Shemer Y, Kol R, Sarov I. Tryptophan reversal of recombinanthuman gamma-interferon inhibition of C. trachomatis growth. Curr Microbiol 1987; 16: 9–13.
  • Thomas SR, Stocker R. Redox reactions related to the indoleamine 2,3-dioxygenase and tryptophan metabolism along the kynurenine pathway. Redox Rep 1999; 4: 199–220.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.